Introduction
The electrophysiological tests
The full-field ERG
The pattern ERG
The multifocal ERG
The electrooculogram
Visual evoked potentials
Clinical indications for visual electrophysiology
Visual acuity loss
Retinal and RPE disorders
Optic nerve/post-retinal disorders
Non-organic visual loss
Night blindness
Night blindness due to rod photoreceptor dysfunction
Night blindness due to dysfunction occurring post-phototransduction
Photophobia
Visual field loss
Disk pallor
Glaucoma
Nystagmus
Vascular retinopathies or ischemic status of retina
Ocular media opacity
Family history of visual pathway disease
Monitoring of disease progression, treatment efficacy and safety
Special considerations and indications for ERG and VEP testing in infants and children
Unexplained visual loss
Congenital nystagmus
Known or suspected hereditary disorders
Perinatal infections
Perinatal brain injury
Trauma
Delayed visual maturation
Monitoring for retinal drug toxicity
Amblyopia
Complementary testing
Subjective assessment of function
Visual acuity
Visual fields
Contrast sensitivity
Color vision testing
Dark adaptometry
Retinal imaging
Fundus photography
Fluorescein angiography
Fundus autofluorescence
Optical coherence tomography
Adaptive optics
Genetic testing
Typical or common fundus/ocular abnormalities | Acquired disorder or gene/s implicateda | Macular function | Rod system function | Cone system function | Comments including VEP, EOG and other electrophysiological findings where relevant | |||
---|---|---|---|---|---|---|---|---|
PERG P50 or MfERG | DA 0.01 | DA10.0 | LA 30 Hz | LA 3.0 | ||||
Adult vitelliform macular dystrophy | Small vitelliform foveal lesion due to a sub-retinal cyst with or without paracentral drusen and mild RPE changes | PRPH2, BEST1, IMPG1, IMPG2 | N/A | N | N | N | N | The EOG is normal or mildly subnormal and distinguishes most cases from Best vitelliform macular dystrophy |
Albinism | Blonde fundus and foveal hypoplasia are common. There may be iris transillumination and nystagmus | TYR, OCA2, TYRP1, SLC45A2, GPR143 | A | N | N | N | N | Multichannel VEPs show bilateral contralateral predominance to pattern onset–offset (adults) or flash stimulation (young children). Assessment of macular function may be precluded by the effects of nystagmus; in the absence of nystagmus there may be evidence of mild macular dysfunction in some cases |
Autosomal dominant vitreoretinochoroidopathy (ADVIRC) | Liquefied vitreous. Preretinal white dots and neovascularization often present. Peri-papillary atrophy can occur. Abnormal pigment often extends to an equatorial demarcation line at the posterior border | BEST1 | A | A | A | A | A | The EOG light peak-to-dark trough ratio is severely abnormal |
Autosomal recessive bestrophinopathy (ARB) | Diffuse RPE irregularity extending to the vascular arcades associated with patchy RPE atrophy and punctate white dots | BEST1 | A/N | A/N | A/N | A/N | A/N | The EOG light peak-to-dark trough ratio is severely abnormal. ERG is initially normal but mild abnormalities usually develop in late childhood or adolescence and then worsen progressively |
Batten disease (Juvenile onset neuronal ceroid lipofuscinosis) | Normal or Bull’s eye lesion | CLN3 | A | A | A (-ve) | A | A (-ve) | Electronegative ERG may be detected before fundus changes. LA 3.0 ERG may have a low b:a ratio |
Birdshot retinochoroidopathy (BRC) | Multiple pale sub-retinal lesions. Inflammatory signs such as vitritis, vasculitis and CME are common | Acquired | A/N | A/N | A(-ve)/N | A/N | A/N | Variable. Mf ERG and PERG often reveal macular dysfunction, especially if there is CME. ERG is normal to abnormal depending on severity and efficacy of treatment. LA 30 Hz ERG commonly delayed and DA strong flash ERGs in some cases have a low b:a ratio |
Best vitelliform macular dystrophy (Best disease) | Variable but often characterized by a vitelliform yellow macular lesion due to a sub-retinal cyst, which may evolve in some to become vitelliruptive with eventual atrophy. Fundus can be normal | BEST1 | N/A | N | N | N | N | The EOG light peak-to-dark trough ratio is abnormal. Macular dysfunction occurs as macular lesions become vitelliruptive |
Bulls-eye maculopathy (BEM) | Concentric paracentral changes with foveal sparing | Acquired or Genetic | A A A | N N A | N N A | N A A+ | N A A+ | Maculopathy or macular dystrophy Cone dystrophy Cone-rod dystrophy PERG/mfERG evidence of macular dysfunction; mfERG may reveal paracentral dysfunction with localized or relative foveal sparing |
Carcinoma Associated Retinopathy (CAR) | Fundus initially normal. RPE atrophy, mottling and vessel attenuation may develop | Acquired | A | A+ | A+ | A+ | A+ | Often severe photoreceptor dysfunction causing an undetectable ERG or severe a-wave reduction. Cone system is most affected in some. In rare cases there is an electronegative ERG |
Central retinal artery occlusion (CRAO) | Inner retinal edema and a cherry red spot at the macula in the early stages. Eventual arteriolar attenuation and disk pallor | Acquired | A (variable) | A | A (-ve) | A | A | Decreased oscillatory potentials. Relative sparing of visual acuity and of the PERG/central mfERGs if there is a cilioretinal artery |
Central retinal vein occlusion (CRVO) | Dilatation and tortuosity of retinal veins, dot and flame hemorrhages, cotton wool spots, optic disk and macular edema, hyperemia. Ischemic form may result in severe vascular leakage and rubeosis | Acquired | A (variable) | A | A(-ve) | A | A | Reduced oscillatory potentials. Ischemic CRVO associated with more severe ERG changes and a more reduced DA ERG b:a ratio than non-ischemic disease. ERG a-wave involvement in severe cases |
Choroideremia | Loss of RPE and choriocapillaris. Inner retina and optic disk normal. Late involvement of macula. | REP1 | A | A+ | A+ | A | A | Severe (+) rod > cone or undetectable ERGs. Late macular involvement. ERG is usually normal in female heterozygotes but worsening can occur from middle age |
Female heterozygotes may show mild pigmentary changes or patchy RPE degeneration | N | N | N | N | N | |||
Cone dystrophy | Fundus may be normal. Disk pallor, granular RPE, bull’s eye lesion, central atrophy | see Ret Net (many) | A | N | N | A | A | See text. PERG and MfERG usually show evidence of severe and early macular involvement |
Cone-rod dystrophy | Fundus may be normal. Disk pallor, granular RPE, bull’s eye lesion, central atrophy. | A | A | A | A+ | A+ | ||
CSNB 1. Schubert–Bornschein | ||||||||
(a) complete | Fundus normal (± myopic changes). | NYX, GRM6, TRPM1, LRIT3, GPR179 | A | U | A (−ve) | A | A | See text for details |
(b) incomplete | Fundus normal (± myopic changes). | CACNA1F, CABP4 | A | A | A (−ve) | A+ | A+ | |
2. Riggs-type | Fundus normal | PDE6B, RHO, GNAT1, SLC24A1 | N | A | A | N | N | See also fundus albipunctatus and Oguchi disease (forms of CSNB with abnormal fundi and delayed dark adaptation) |
Dominant optic atrophy (DOA) | Disk pallor typically wedge shaped and temporal but may be diffuse | OPA1, OPA3, OPA4, OPA5, OPA8 | PERG P50 N or mildly subnormal and of short peak time MfERG N | N | N | N | N | PERG N95 may be abnormal in early stages. In severe cases PERG P50 may be reduced with shortening of P50 peak time. Pattern VEP often shows delay and reduction but abnormalities can be mild in the early stages |
Enhanced S-cone syndrome (Goldman Favre disease) | Normal to nummular pigment clumping in RPE in vicinity of vascular arcades. Macular schisis can occur | NR2E3 | A | U | A | A+ | A | Pathognomonic ERG abnormalities. DA3, DA10 and LA3 ERGs are severely delayed with a simplified waveform. LA3 ERG a-wave is larger than the severely abnormal LA 30 Hz ERG. S-cone ERG is enlarged |
Fundus albipunctatus | Multiple small white/yellow spots with sparing of the macula | RDH5 | A/N | A | A | A/N | A/N | See text. DA ERGs improve or normalize after prolonged dark adaptation. Approximately 50% have mild LA ERG abnormalities |
Glaucoma | Disk cupping, nerve fiber loss | Acquired | PERG abnormal MfERG normal | N/A | N/A | N/A | N/A | VEP may be normal or mildly abnormal unless severe/advanced disease. Steady-state PERG more sensitive than transient PERG for monitoring purposes. PhNR may be used to assess global retinal ganglion cell function |
Ischemic optic neuropathy. | In arteritic form optic disk swelling, disk pallor ± flame hemorrhages | Acquired | PERG P50 N or mildly subnormal and of short peak time MfERG N | N | N | N | N | Pattern VEPs show reduction without significant delay. More severe in arteritic (AAION) than non-arteritic (NAION) cases. There may be eventual PERG N95 reduction in keeping with retinal ganglion cell dysfunction and with reduction/shortening of P50 peak time in some. Usually unilateral |
KCNV2-retinopathy (“Cone dystrophy with supernormal rod ERG”) | Normal in young but BEM and macular RPE atrophy may develop. Disk pallor in some. Peripheral retina normal | KCNV2 | U | A | A | A | A | Pathognomonic ERG abnormalities. Generalized cone system dysfunction with unusual rod system involvement; DA ERGs to dim flashes are small and delayed and ERG b-waves to strong flashes large. DA 10 ERG a-wave has a distinctive broad trough with a late negative component |
Leber congenital amaurosis (LCA) | Pigmentary & atrophic changes with age. Hypoplastic/swollen disks common | see Ret Net (many) | A | A+ | A+ | A+ | A+ | ERG typically undetectable or severely reduced from early infancy |
Leber hereditary optic neuropathy (LHON) | Nerve fiber layer swelling in acute stages. Enlarged or telangiectatic and tortuous peri-papillary vessels. Optic atrophy | G11778A, T14484C, G3460A | PERG P50 N or mildly subnormal and of short peak time MfERG usually N | N | N | N | N | PERG N95 may be abnormal in acute stage. Pattern VEPs are undetectable or severely abnormal. Absence of fluorescein leakage from the swollen disk, distinguishing LHON from other forms of disk swelling. |
Melanoma-associated retinopathy (MAR) | Fundus usually normal. Vitreous cells, vessel attenuation and disk pallor may develop in some | Acquired | A | U | A(-ve) | A | A | Long-duration On–Off ERG shows On response b-wave reduction with sparing of the Off -response. Full-field ERGs identical to those in complete CSNB |
Oguchi disease | Golden fundus sheen which resolves following prolonged dark adaptation (Mizuo–Nakamura phenomenon) | SAG, rhodopsin kinase | N | U | A | N | N | DA ERGs show severe rod dysfunction after 20 min in the dark. LA ERGs are normal. After prolonged DA a single strong flash elicits a normal ERG; subsequent flashes elicit subnormal responses and further prolonged DA is needed to recover |
Optic neuritis | Disk pallor and thinning of retinal nerve fiber layer may be evident | Acquired | PERG P50 N or mildly subnormal and of short peak time MfERG N | N | N | N | N | Pattern VEP is usually delayed with or without amplitude reduction. PERG P50 is usually normal but in 35% cases there is PERG N95 reduction in keeping with retinal ganglion cell dysfunction and with reduction/shortening of P50 peak time in some. May be subclinical involvement of the other eye |
Pattern dystrophy | Various patterns of pigment deposition within the macula including adult-onset vitelliform macular dystrophy, butterfly-shaped, reticular, multifocal pattern dystrophies and fundus pulverentulus | PRPH2 | A/N | N | N | N | N | The EOG is normal or mildly subnormal. The ERG is usually normal although there can be marked variability in fundus appearance and ERG phenotype within families with PRPH2 mutation |
Retinitis Pigmentosa (RP; Rod-cone dystrophy) | Classically bone-spicule formation, RPE atrophy, attenuated vessels, disk pallor. Normal or near-normal in some | see Ret Net (many). | A/N | A+ | A+ | A | A | See text. Rod-cone dystrophy of variable severity. Variable macular involvement. In X-linked pedigrees, female heterozygotes usually have ERG abnormalities with inter-ocular ERG asymmetry |
Rod monochromacy (“Achromatopsia”) | Usually normal, macular granularity may develop | CNGA3, CNGB3, GNAT2, PDE6C, PDE6H, ATF6 | A | N | N/sl. A | U | U | See text. There may be mild reduction in DA strong flash ERGs due to loss of the normal cone system contribution to the a- and b-waves |
Retinal toxicity (selected examples) | Chloroquine/Hydroxychloroquine | Acquired | A | N/A | N/A | N/A | N/A | MfERG shows annular macular dysfunction in early stages with later central involvement. ERG abnormal in severe cases |
Desferrioxamine | A | N/A | N/A | N/A | N/A | Macular dysfunction most common; PERG/mfERG ± ERG abnormality. ERG may be normal but ranges from showing mild rod dysfunction to severe cone-rod dysfunction | ||
Quinine | A | A | A(-ve) | A | A | On response electronegative; Off d-wave has an abnormal shape | ||
Retinitis punctata albescens (Bothnia dystrophy; rod-cone dystrophy) | Multiple small white/yellow spots with sparing of the macula. Diffuse RPE degeneration, scalloped peripheral atrophy and pigment deposition in late stages | RLBP1 | A/N | A | A | A | A | Resembles fundus albipunctatus in early stages and DA ERGs may show partial improvement after prolonged dark adaptation. Eventual progressive rod-cone dystrophy |
RGS9 / R9AP – retinopathy (“Bradyopsia”) | Fundus normal | RGS9, R9AP | PERG U | N | SI. A | U | A+ | DA 10 ERG mildly abnormal unless inter-stimulus interval is increased e.g. to 1-2 mins. Scotopic red flash ERG reveals normal rod and good DA cone function, in spite of severe LA ERG abnormalities. |
S-cone monochromacy (“X-linked incomplete achromatopsia”) | Usually normal, macular granularity may develop | OPN1LW, OPN1MW | A | N | N/sl. A | U | A | A preserved S-cone ERG distinguishes the disorder from rod monochromacy. There may be relatively mild reduction in DA 0.01 and DA10 ERG a-waves due to high myopia and loss of cone system contribution to the strong flash ERG a- and b-waves |
Stargardt disease/fundus flavimaculatus (ABCA4-retinopathy) | Central atrophy with flecks or widespread flecks across posterior pole with peri-papillary sparing. Extensive RPE atrophy in severe cases | ABCA4 | A A A | N N A | N N A | N A A | N A A | Macular dystrophy Cone dystrophy Cone-rod dystrophy In all 3 phenotypes there is PERG/mfERG evidence of macular dysfunction |
Vitamin A deficiency | Normal or white spots across the fundus | Acquired | N | A | A | N | N | See text. |
X-linked retinoschisis | Macular cysts common; may progress to macular atrophy in older men. Peripheral schisis occurs in about 50% of cases | RS1 | A | A | A(-ve) | A | A | On b-wave ± OFF d-wave subnormal. Inner retinal dysfunction of variable severity. PERG and mfERG usually abnormal |
Index
A
| |
Achromatopsia (rod monochromacy) | 12, 17, 23, 24 |
Acute zonal occult outer retinopathy (AZOOR) | 12, 13 |
Adult vitelliform macular dystrophy | 10, 19 |
Albinism | 12, 13, 14, 15, 19 |
Amblyopia | 14, 16 |
Arteritic anterior ischemic optic neuropathy (AAION) | 10, 22 |
Autoimmune retinopathy (AIR) | 10, 12, 13 |
Autosomal dominant vitreoretinochoroidopathy (ADVIRC) | 9, 19 |
Autosomal recessive bestrophinopathy (ARB) | 9, 19 |
B
| |
Batten disease (juvenile onset neuronal ceroid lipofuscinosis) | 19 |
Best vitelliform macular dystrophy (Best disease) | 10, 20 |
Birdshot retinochoroidopathy (BRC) | 2, 12, 14, 19 |
Bulls-eye maculopathy | 9, 14, 19, 20 |
C
| |
Carcinoma Associated Retinopathy (CAR) | 10, 11, 12, 20 |
Central retinal artery occlusion (CRAO) | 12, 20 |
Central retinal vein occlusion (CRVO) | 13, 20 |
Central serous chorioretinopathy (CSR) | 12, 14 |
Chiasmal dysfunction | 8, 10, 17 |
Chloroquine | 23 |
Choroideremia | 14, 20 |
Compressive lesions | 10 |
Cone & cone-rod dystrophy | 2, 9, 12, 13, 18, 20, 22 |
Congenital nystagmus | 13, 15 |
Congenital Stationary Night Blindness (CSNB) | 2, 11, 13, 15, 17, 18, 21 |
D
| |
Delayed visual maturation (DVM) | 16 |
Demyelination | 10 |
Desferrioxamine | 23 |
Disc pallor | 12, 20, 21, 22, 23 |
Dominant optic atrophy (DOA) | 10, 14, 21 |
E
| |
Enhanced S-cone syndrome | 18, 21 |
Ethambutol | 10 |
F
| |
Fundus albipunctatus | 11, 21, 24 |
Fundus flavimaculatus (ABCA4-retinopathy) | 9, 24 |
G
| |
Glaucoma | 13, 16, 21 |
H
| |
Hydroxychloroquine | 9, 14, 23 |
I
| |
Ischemic optic neuropathy (AAION; NAION) | 6, 10, 12, 22 |
J
| |
Juvenile onset neuronal ceroid lipofuscinosis (Batten disease) | 19 |
K
| |
KCNV2-retinopathy (Cone dystrophy with supernormal rod ERG) | 18, 22 |
L
| |
Leber congenital amaurosis (LCA) | 13, 15, 22 |
Leber hereditary optic neuropathy (LHON) | 10, 22 |
M
| |
Macular dystrophy/maculopathy | 2, 6, 7, 9, 10, 12, 14, 18, 19, 20, 24 |
Melanoma Associated Retinopathy (MAR) | 11, 12, 18, 22 |
Methyl-alcohol poisoning | 10 |
N
| |
Night blindness | 11, 15, 17 |
Non-arteritic anterior ischemic optic neuropathy (NAION) | 6, 10, 22 |
Non-organic visual loss | 10 |
Nystagmus | 8, 13, 15, 19 |
O
| |
Occult macular dystrophy/occult maculopathy | 9, 10, 12, 18 |
Oguchi disease | 11, 22 |
Optic nerve dysfunction | 6, 8, 9, 10, 13, 14, 16 |
Optic neuritis | 6, 8, 10, 13, 16, 23 |
P
| |
Paraneoplastic retinopathy (CAR, MAR) | 10, 11, 12, 13, 17, 20, 22 |
Pattern dystrophy | 10, 23 |
Perinatal brain injury | 16 |
Perinatal infection | 15 |
Photophobia | 12 |
Photopic negative response (PhNR) | 13, 21 |
Phototoxic maculopathy | 14 |
Q
| |
Quinine | 23 |
R
| |
Retinal and RPE disorders | 9 |
Retinal detachment | 12, 14, 18 |
Retinal toxicity | 14, 16, 23 |
Retinitis Pigmentosa (RP; rod cone dystrophy) | 2, 6, 11, 12, 14, 15, 17, 23 |
Retinitis punctata albescens (Bothnia dystrophy) | 11, 24 |
Retrochiasmal dysfunction | 8, 10, 12 |
RGS9/R9AP-retinopathy | 18, 24 |
Rod monochromacy (achromatopsia) | 12, 13, 15, 23 |
Rubella retinopathy | 14, 16 |
S
| |
S-cone monochromacy (X-linked incomplete achromatopsia) | 12, 13, 15, 24 |
Silicone oil | 14 |
Stargardt disease (ABCA4-retinopathy) | 9, 24 |
T
| |
Tobacco toxicity | 10 |
TORCH | 15 |
Trauma | 16 |
U
| |
Unexplained visual loss | 10, 15 |
V
| |
Vascular Retinopathies | 12, 13, 20 |
Vigabatrin | 16 |
Vitamin A deficiency | 11, 12, 17, 24 |
Vitamin B12 deficiency | 10, 13 |
X
| |
X-linked retinoschisis | 12, 24 |
X-linked RP | 14, 15 |